ST Segment Yükselmeli Miyokard İnfarktüsü Hastalarında Koroner Arter Hastalığının Ciddiyeti ile Serum Adropin Seviyesi Arasındaki İlişkinin Değerlendirilmesi

Amaç: Adropin doku ve organların enerji balansı ile ilişkilidir. SYNTAX skor (SS) ST segment yükselmeli miyokard infraktüsünün (STYMI) ciddiyetinin değerlendirilmesinde kullanılmaktadır. Bu çalışmada serum adropinseviyesiile STYMI hastalarının hastalık ciddiyeti arasındaki ilişkinin araştırılması amaçlandı. GereçveYöntemler: STYMI sebebiyle koroner anjiografi (KAG) yapılan 89 hasta çalışmaya dahil edildi. STYMI hastalar Grup 1 (SS

An Analysis on Coronary Artery Disease Severity with Serum Adropin Level in Patients with Acute ST-Segment Elevation Myocardial Infarction

Objective: Adropin is associated with energy balance in tissues and organs. The SYNTAX score (SS) is used to determine the severity of ST-segment elevation myocardial infarction (STEMI). The aim of this study was to determine the relationship between serum adropin levels and disease severity in STEMI patients. Materials and Methods: Eighty-nine patients who underwent coronary angiography (CAG) for STEMI were included in the study. The STEMI patients were divided into two subgroups: Group 1(SS

___

  • 1. Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). European heart journal 2019; 40(3): 237-69.
  • 2. Hassan AK, Bergheanu SC, Hasan-Ali H, et al. Usefulness of peak troponin-T to predict infarct size and long-term outcome in patients with first acute myocardial infarction after primary percutaneous coronary intervention. The American journal of cardiology 2009; 103(6): 779-84.
  • 3. Danese E and Montagnana M. An historical approach to the diagnostic biomarkers of acute coronary syndrome. Ann Transl Med 2016; 4(10): 194. doi: 10.21037/atm.2016.05.19.
  • 4. Mythili S and Malathi N. Diagnostic markers of acute myocardial infarction. Biomed Rep 2015; 3(6): 743-8.
  • 5. Kumar KG, Trevaskis JL, Lam DD, et al. Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism. Cell Metab 2008; 8: 468-81.
  • 6. Yosaee S, Soltani S, Sekhavati E, et al. Adropin- A Novel Biomarker of Heart Disease: A Systematic Review Article. Iran J Public Health 2016; 45: 1568-76.
  • 7. Yu HY, Zhao P, Wu MC, et al. Serum adropin levels are decreased in patients with acute myocardial infarction. Regul Pept 2014; 191: 46-49.
  • 8. Lian W, Gu X, Qin Y, et al. Elevated plasma levels of adropin in heart failure patients. Intern Med 2011; 50(15): 1523-7.
  • 9. Zhao LP, Xu WT, Wang L, et al. Serum adropin level in patients with stable coronary artery disease. Heart, lung & circulation 2015; 24(10): 975-9.
  • 10. Sianos G, Morel MA, Kappetein AP, et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 2005; 1(2): 219-27.
  • 11. Farooq V, Serruys PW, Bourantas CV, et al. Quantification of incomplete revascularization and its association with five-year mortality in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial validation of the residual SYNTAX score. Circulation 2013; 128(2): 141-51.
  • 12. Brown AJ, McCormick LM, Gajendragadkar PR, et al. Initial SYNTAX score predicts major adverse cardiac events after primary percutaneous coronary intervention. Angiology 2014; 65(5): 408-12.
  • 13. Aydin S, Kuloglu T, Aydin S, et al. Expression of adropin in rat brain, cerebellum, kidneys, heart, liver, and pancreas in streptozotocin-induced diabetes. Mol Cell Biochem 2013; 380: 73-81.
  • 14. Ganesh Kumar K, Zhang J, Gao S, et al. Adropin deficiency is associated with increased adiposity and insulin resistance. Obesity (Silver Spring) 2012; 20(7): 1394-402.
  • 15. Diez-Delhoyo F, Gutierrez-Ibanes E, Sanz-Ruiz R, et al. Prevalence of Microvascular and Endothelial Dysfunction in the Nonculprit Territory in Patients With Acute Myocardial Infarction. Circ Cardiovasc Interv 2019; 12(2): doi: 10.1161/ circinterventions.118.007257.
  • 16. Qiu CR, Fu Q, Sui J, et al. Serum Endothelial Cell-Specific Molecule 1 (Endocan) Levels in Patients With Acute Myocardial Infarction and Its Clinical Significance. Angiology 2017; 68: 354-9.
  • 17. Lovren F, Pan Y, Quan A, et al. Adropin is a novel regulator of endothelial function. Circulation 2010; 122: 185-92.
  • 18. Chen X, Xue H, Fang W, et al. Adropin protects against liver injury in nonalcoholic steatohepatitis via the Nrf2 mediated antioxidant capacity. Redox Biol 2019; 21: 101068. 2019/01/27. doi: 10.1016/j.redox.2018.101068.
  • 19. Zhao LP, You T, Chan SP, et al. Adropin is associated with hyperhomocysteine and coronary atherosclerosis. Exp Ther Med 2016; 11: 1065-70.
  • 20. Ertem AG, Unal S, Efe TH, et al. Association between serum adropin level and burden of coronary artery disease in patients with non-ST elevation myocardial infarction. Anatol J Cardiol 2017; 17(2): 119-24.
Sakarya Tıp Dergisi-Cover
  • Başlangıç: 2011
  • Yayıncı: Sakarya Üniversitesi
Sayıdaki Diğer Makaleler

ST Segment Yükselmeli Miyokard İnfarktüsü Hastalarında Koroner Arter Hastalığının Ciddiyeti ile Serum Adropin Seviyesi Arasındaki İlişkinin Değerlendirilmesi

Mustafa ÖZTÜRK, Oguzhan Ekrem TURAN, Engin ŞEBİN, Gökhan CEYHUN, Emrah AKSAKAL, Kamuran KALKAN, Oktay GULCU, Ali KORKMAZ, Murat BAYANTEMUR

Frenchay Aktiviteler İndeksinin Türkçe Versiyonunun Psikometrik Özelliklerinin Değerlendirmesi ile Kültürel Adaptasyonu

Nuray ALACA

Çocuk ve Ergen Psikiyatrisi Polikliniğine Başvuran Hastaların Tanı Dağılımı ve Tedavilerinin Değerlendirilmesi

Şenay KILINÇEL

Covid-19 Pandemisinde Mikrobiyoloji Laboratuvar Tanı Metodları

Canan EREN

Preterm ve Term Yenidoğanlarda İlk Banyo Zamanlarının ve Farklı Banyo Yöntemlerinin Termoregülasyona Etkisi: Sistematik Derleme

Atiye KARAKUL, Pınar DOĞAN

Ameliyathane Dışı Anestezi(ADA) Uygulanan Endobronşial Ultrasonografi (EBUS) İşlemlerinde Premedikasyon İlaçlarının Entegre Pulmoner İndeks Skoruna Etkisi

Leyla KAZANCIOĞLU, Hizir KAZDAL

ST Segment Yükselmeli Miyokard İnfarktüsü ile Başvuran Hastalarda Hastane İçi ve Uzun Dönem Mortalitenin Değerlendirilmesi: Üçüncü Basamak Kardiyoloji Merkezi Deneyimi

Göktuğ SAVAŞ, Mehmet KIZILAY, Melek SÜZER

Bariatrik Cerrahi Olgularında Preoperatif Değerlendirme Sırasında Tespit Edilen Hastalıkların Prevalansı

Feyzi GÖKOSMANOĞLU, Kerim GÜZEL, Gülşah BAYÇELEBİ

Incidance, Treatment Options and Outcomes of Stent Loss During Percutaneous Coronary Intervention: A Single-Center Experience

Yusuf CAN, İbrahim KOCAYİĞİT, Muhammed AKSOY

Periton diyalizi hastalarının periton diyalizinden ayrılma nedenleri: tek merkez deneyimi

Necmi EREN, Yasin ERYILMAZ, Metin ERGÜL, Nuriye YILDIZ, Sibel BALCI, Sibel BEK, Erkan DERVİŞOĞLU, Betul KALENDER